Tone mix
Week by week 52 weeks
Share of GSK plc American Depositary Shares (Each representing two Ordinary Shares)'s 815 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Dec 29, 2025 · tone +83HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target+56
- Week of Nov 17, 2025 · tone -17JPMorgan Lowers GSK Price Target, Maintains Underweight Rating-53
- Week of Jun 29, 2026 · tone 0GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share-48
- Week of Aug 3, 2026 · tone -18Weekly Buzz: Cipla, Viatris Win FDA Nod; Boston Scientific Cuts Jobs; argenx Snaps Up Forte Biosciences; Johnson & Johnson, GSK Strike Deals-47
- Week of Jul 6, 2026 · tone -4AstraZeneca, GSK intensify China ties with Sino Biopharm deals-45
- Week of Dec 15, 2025 · tone +89GSK'227 Wins FDA Orphan Drug Designation in Small-Cell Lung Cancer+43
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about GSK plc American Depositary Shares (Each representing two Ordinary Shares) in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 33 | +24 |
| Last 30 sessions | 89 | +38 |
| Last 90 sessions | 226 | +33 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
5 headlines, average tone -60: 0 positive, 2 neutral and 3 negative. Showing all 5.
- www.theguardian.com · 1 outletGSK shares dive as weaker sales and mounting costs unnerve investorsNegative
- www.investors.com · 1 outletGSK Stock Tumbles As Vaccine Sales Dip, Dragging On Topline BeatNegative
- www.standard.co.uk · 1 outletGSK sees falling vaccine sales take shine off earningsNegative
- www.fool.com · 1 outletGSK (GSK) Q3 2026 Earnings Call TranscriptNeutral
- 247wallst.com · 1 outletGSK (GSK) Stock Price, News & AnalysisNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| GSK shares dive as weaker sales and mounting costs unnerve investors | www.theguardian.com | 1 | Negative |
| GSK Stock Tumbles As Vaccine Sales Dip, Dragging On Topline Beat | www.investors.com | 1 | Negative |
| GSK sees falling vaccine sales take shine off earnings | www.standard.co.uk | 1 | Negative |
| GSK (GSK) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
| GSK (GSK) Stock Price, News & Analysis | 247wallst.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
10 headlines, average tone +10: 5 positive, 1 neutral and 4 negative. The 8 most widely carried stories are listed; the table holds all 10.
- www.rttnews.com · 2 outletsGSK Q3 Core Operating Profit Rises; Reaffirms 2026 GuidancePositive
- www.channelnewsasia.com · 2 outletsGSK to nearly double cancer medicines in clinical trials next yearPositive
- www.rte.ie · 1 outletGSK third-quarter beat fails to impress and shares fallNegative
- www.aol.co.uk · 1 outletGSK shares dive as weaker sales and mounting costs unnerve investorsNegative
- healthcare-digital.com · 1 outletGSK's Positive Cancer Trial Results Reveal Oncology MomentumPositive
- www.aol.co.uk · 1 outletGSK sees falling vaccine sales take shine off earningsNegative
- seekingalpha.com · 1 outletGSK delivers Q3 earnings beat, reaffirms 2026 outlook (GSK:NYSE)Positive
- www.proactiveinvestors.com · 1 outletVaccines worries hit GSKNegative
Show the table · 10 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| GSK Q3 Core Operating Profit Rises; Reaffirms 2026 Guidance | www.rttnews.com | 2 | Positive |
| GSK to nearly double cancer medicines in clinical trials next year | www.channelnewsasia.com | 2 | Positive |
| GSK third-quarter beat fails to impress and shares fall | www.rte.ie | 1 | Negative |
| GSK shares dive as weaker sales and mounting costs unnerve investors | www.aol.co.uk | 1 | Negative |
| GSK's Positive Cancer Trial Results Reveal Oncology Momentum | healthcare-digital.com | 1 | Positive |
| GSK sees falling vaccine sales take shine off earnings | www.aol.co.uk | 1 | Negative |
| GSK delivers Q3 earnings beat, reaffirms 2026 outlook (GSK:NYSE) | seekingalpha.com | 1 | Positive |
| Vaccines worries hit GSK | www.proactiveinvestors.com | 1 | Negative |
| GSK Oncology Chief Tells WSJ Pipeline Could Nearly Double in 2027 | econotimes.com | 1 | Positive |
| Financial Survey: GSK (NYSE:GSK) and Organon & Co. (NYSE:OGN) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 27, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.thehindubusinessline.com · 1 outletGSK to nearly double cancer drugs in trials next year, WSJ reportsPositive
- www.dailypolitical.com · 1 outletGSK (NYSE:GSK) vs. Palisade Bio (NASDAQ:PALI) Financial ReviewNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| GSK to nearly double cancer drugs in trials next year, WSJ reports | www.thehindubusinessline.com | 1 | Positive |
| GSK (NYSE:GSK) vs. Palisade Bio (NASDAQ:PALI) Financial Review | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
4 headlines, average tone +4: 1 positive, 2 neutral and 1 negative. Showing all 4.
- www.rttnews.com · 1 outletGSK: AZUR-1 Data Demonstrates Potential Of JemperliPositive
- www.aol.com · 1 outletCan Specialty Meds Offset GSK's $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28?Negative
- www.newsweek.com · 1 outletSeeking Value: GSK's Drug-Safety AI Strategy Connects Data With OutcomesNeutral
- www.dailypolitical.com · 1 outletGSK PLC Sponsored ADR (NYSE:GSK) Stock Has Consensus Price Target of $55.33 According to AnalystsNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| GSK: AZUR-1 Data Demonstrates Potential Of Jemperli | www.rttnews.com | 1 | Positive |
| Can Specialty Meds Offset GSK's $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28? | www.aol.com | 1 | Negative |
| Seeking Value: GSK's Drug-Safety AI Strategy Connects Data With Outcomes | www.newsweek.com | 1 | Neutral |
| GSK PLC Sponsored ADR (NYSE:GSK) Stock Has Consensus Price Target of $55.33 According to Analysts | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
2 headlines, average tone -2: 1 positive, 0 neutral and 1 negative. Showing all 2.
- www.rttnews.com · 1 outletGavi, UNICEF Cut GSK Mosquirix Vaccine Price By 40%Negative
- www.raps.org · 1 outletRecon: FDA approves GSK hepatitis B drug; EQT to buy molecular testing firm Qiagen for $10.8BPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Gavi, UNICEF Cut GSK Mosquirix Vaccine Price By 40% | www.rttnews.com | 1 | Negative |
| Recon: FDA approves GSK hepatitis B drug; EQT to buy molecular testing firm Qiagen for $10.8B | www.raps.org | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about GSK plc American Depositary Shares (Each representing two Ordinary Shares), not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.